New York Attorney General Letitia James (Bebeto Matthews/AP Images)
February 26, 2024 02:00 PM ESTUpdated 04:42 PM
Pharma
FDA+

New York AG calls for 'more strin­gen­t' Sin­gu­lair safe­ty warn­ings

Nicole DeFeudis

Editor

New York At­tor­ney Gen­er­al Leti­tia James wants an “ur­gent” re­view of the safe­ty la­bel for a decades-old asth­ma and al­ler­gy med­ica­tion.

James last week …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

A service from the Financial Times